Doctors 2.0 & You The Most Tweeted Two-Day Healthcare Conference in Europe

Doctors 2.0 & You5 - 6 June 2014, Paris, France.
Doctors 2.0 & You, the digital healthcare conference in Europe, and Symplur, LLC, partners for the promotion of advanced Twitter analytics, announced new data regarding the #Doctors20 hashtag associated to the most recent edition of the conference. The data focused on Twitter conversations using the #Doctors20 hashtag during the "Doctors 2.0 & You" June 6-7, 2013 gathering in Paris.

With 7,464 tweets over the two day event and just over 400 people present, Doctors 2.0 & You has become the second most tweeted healthcare conference in Europe of all time, second only to the 9 000 tweets of the four-day European Society of Cardiology Congress (#ESCcongress), which attracted 30 000 visitors. What's more, the Twitter conversation that was centered around the Doctors 2.0 & You hashtag increased by nearly 50% over the previous year's tweet activity.

Among the key findings, via an analysis of the actual vocabulary used by participants, it was discovered that the words "patients, patient, and doctors" were the top three keywords used in tweets bearing the #Doctors20 hashtag during the conference.

Denise Silber, founder of Doctors 2.0 & You, and an eHealth pioneer, noted that, "We are very pleased by these findings. The patient-physician relationship is key to all stakeholders and as to the numbers, we are humbled to know we've come this far in 2013. Our partnership with Symplur is strategic, given our analysis of the importance of Twitter."

Doctors 2.0 & You and Symplur, LLC have again partnered to deliver a cutting-edge environment for building up to and sharing this year's event via social media. Symplur will provide an external perspective on the Doctors 2.0 & You hashtag #Doctors20 ... Doctors 2.0 & You will bring a Twitter savvy, active audience to Symplur. In 2013, Symplur and Doctors 2.0 & You debuted a groundbreaking technology during the conference, live analytics that visually demonstrated the trends and impact of the unfolding conversation on Twitter. Symplur and Doctors 2.0 & You are currently collaborating on an exciting, social media related research project that will be of interest to healthcare professionals, patients, and to industry insiders of all sorts.

About Doctors 2.0 & You
The Doctors 2.0TM & You conference series, organized by Basil Strategies, digital health consultancy (Paris), is the only international congress devoted to the understanding of how physicians use New Technologies, Web 2.0 tools and Social Media to communicate with colleagues, patients, payers, pharmaceutical companies and public agencies. The 4th edition will take place in Paris on June 5-6, 2014. The conference website and blog includes videos, past presentations, interviews, and other content. See http://www.doctors20.com.

About Symplur
Symplur has the largest database of healthcare conversations on Twitter today. Having created The Healthcare Hashtag Project over three years ago to serve the healthcare social media community, Symplur has since stored over 350 million health related tweets, all categorized over thousands of health topics. Today, Symplur assists healthcare decision makers, researchers and healthcare providers with deep insights from analyzing this large, ever growing dataset.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...